Edward Henegar, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 404 Highway 160, Gainesville, MO 65655 Phone: 417-679-4613 |
News Archive
A new family of contrast agents that sneak into bacteria disguised as glucose food can detect bacterial infections in animals with high sensitivity and specificity. These agents - called maltodextrin-based imaging probes - can also distinguish a bacterial infection from other inflammatory conditions.
In an article published in SPIE's Journal of Medical Imaging, researchers announce critical advances in the use of 3D-printed coronary phantoms with diagnostic software, further developing a non-invasive diagnostic method for Coronary Artery Disease risk assessment.
Men and women should educate themselves and use caution before taking nutritional supplements to reduce their cancer risks, according to experts at UT MD Anderson Cancer Center.
In a study that could lead to new therapeutic targets for patients with the cystic fibrosis, a research team from the University of California, San Diego School of Medicine has identified a defective signaling pathway that contributes to disease severity.
Hyperion Therapeutics, Inc. today announced that the Company's phase III pivotal study of glycerol phenylbutyrate (HPN-100), an investigational drug for the treatment of urea cycle disorders (UCDs), met its primary endpoint. The non-inferiority study, conducted under a Special Protocol Assessment (SPA) granted by the U.S. Food and Drug Administration (FDA) in June 2009, evaluated the ammonia control of glycerol phenylbutyrate as compared to sodium phenylbutyrate (BUPHENYL®).
› Verified 5 days ago